Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anne Simoneau"'
Autor:
Dan Mercola, Michael McClelland, Joseph Monforte, Thomas Beach, Waldemar Lernhardt, Manuel Sutton, Frank Meyskens, Anne Simoneau, Jessica Wang-Rodriguez, Philip Carpenter, Steve Goodison, James A. Koziol, Tolga Turan, Rebecca Pio, Qiang Xu, Xiao-Qin Xia, Farahnaz Rahmatpanah, Huazhen Yao, Anne Sawyers, Yipeng Wang, Zhenyu Jia
More than one million prostate biopsies are performed in the United States every year. A failure to find cancer is not definitive in a significant percentage of patients due to the presence of equivocal structures or continuing clinical suspicion. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ff1055dce7298291f057a14eaa8ef1
https://doi.org/10.1158/0008-5472.c.6503012.v1
https://doi.org/10.1158/0008-5472.c.6503012.v1
Autor:
Dan Mercola, Michael McClelland, Joseph Monforte, Thomas Beach, Waldemar Lernhardt, Manuel Sutton, Frank Meyskens, Anne Simoneau, Jessica Wang-Rodriguez, Philip Carpenter, Steve Goodison, James A. Koziol, Tolga Turan, Rebecca Pio, Qiang Xu, Xiao-Qin Xia, Farahnaz Rahmatpanah, Huazhen Yao, Anne Sawyers, Yipeng Wang, Zhenyu Jia
Supplementary Tables 1-4, Figures 1-4 from Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c95c04bfb45af258b1b0d0a30ed423c
https://doi.org/10.1158/0008-5472.22390664
https://doi.org/10.1158/0008-5472.22390664
Publikováno v:
The Prostate. 53:263-276
BACKGROUND To determine whether human polyomavirus (hPy) genomes are present in prostate tissues, we have carried out a polymerase chain reaction (PCR) screening in two sets of prostate samples, archival and fresh frozen, as well as performing in sit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059926c186b3a3de168b971b5cc3c809
https://doi.org/10.1002/pros.10157
https://doi.org/10.1002/pros.10157
Autor:
Cheryl-Anne Simoneau
Publikováno v:
Clinical journal of oncology nursing. 17(1)
The tremendous progress made in chronic myeloid leukemia (CML) treatment affords patients more options than ever. Five currently available BCR-ABL inhibitors form the mainstay of CML treatment, including first-generation imatinib and more potent seco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c796600be6141c6ba6efab92f6cc511
https://pubmed.ncbi.nlm.nih.gov/23372106
https://pubmed.ncbi.nlm.nih.gov/23372106